Ligand Pharmaceuticals Incorporated
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $1.49B
Liabilities Breakdown FY2019
Total Liabilities: $727.7M
Asset Breakdown
Total Assets: $1.49B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $71.5M | 4.8% |
| Accounts Receivable | $30.4M | 2.0% |
| Inventory | $7.3M | 0.5% |
| Property, Plant & Equipment | $7.2M | 0.5% |
| Goodwill | $95.2M | 6.4% |
| Intangible Assets | $210.4M | 14.1% |
| Other Assets | $1.07B | 71.8% |
Liabilities Breakdown
Total Liabilities: $727.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.4M | 0.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $725.3M | 99.7% |